RBC Capital Lowers Merck Price Target to $140 From $145
RBC Capital maintained its Sector Perform rating on Merck & Co and lowered its price target to $140 from $145.
Story updates
05:01:06 PM UTC
SquawkNews
Merck Price Target Cut to $140.00/Share From $145.00 by RBC Capital